Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study

References

• Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. 2011;20(13):1345–55.
   PubMedGoogle Scholar
• Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, et al. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum. 2009;60(6):1733–42.
   PubMedGoogle Scholar
• Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94–124.
   PubMedGoogle Scholar
• Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol. 2001;28(4):761–5.
   PubMedGoogle Scholar
• Shigemura T, Nakamura J, Kishida S, Harada Y, Ohtori S, Kamikawa K, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023–8.
   PubMedGoogle Scholar
• Mak A. Orthopedic surgery and its complication in systemic lupus erythematosus. World J Orthop. 2014;5(1):38–44.
   PubMedGoogle Scholar
• Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman S, Figgie MP, Mandl LA. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991–2005. J Rheumatol. 2014; 41(5):867–74.
   PubMedGoogle Scholar
• Cruess RL. Osteonecrosis of bone. Current concepts as to etiology and pathogenesis. Clin Orthop Relat Res. 1986;(208):30–9.
   Google Scholar
• Boss JH, Misselevich I. Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol. 2003;40(4):345–54.
   PubMedGoogle Scholar
• Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis. 2000;59(6):462–7.
   PubMedGoogle Scholar
• Klipper AR, Stevens MB, Zizic TM, Hungerford DS. Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore). 1976;55(3):251–7.
   PubMedGoogle Scholar
• Smith FE, Sweet DE, Brunner CM, Davis JSt. Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis. 1976;35(3):227–32.
   PubMedGoogle Scholar
• Abeles M, Urman JD, Rothfield NF. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med. 1978;138(5):750–4.
   PubMedGoogle Scholar
• Asherson RA, Liote F, Page B, Meyer O, Buchanan N, Khamashta MA, et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol. 1993;20(2):284–8.
   PubMedGoogle Scholar
• Nagasawa K, Ishii Y, Mayumi T, Tada Y, Ueda A, Yamauchi Y, et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis. 1989; 48(8):672–6.
   PubMedGoogle Scholar
• Harrington KD, Murray WR, Kountz SL, Belzer FO. Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am. 1971;53(2):203–15.
   PubMedGoogle Scholar
• Murray WR. Hip problems associated with organ transplants. Clin Orthop Relat Res. 1973;(90):57–69.
   Google Scholar
• Heimann WG, Freiberger RH. Avascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy. N Engl J Med. 1960;263:672–5.
   PubMedGoogle Scholar
• Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985;79(5):596–604.
   PubMedGoogle Scholar
• Migliaresi S, Picillo U, Ambrosone L, Di Palma G, Mallozzi M, Tesone ER, Tirri G. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus. 1994;3(1):37–41.
   PubMedGoogle Scholar
• Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol. 1998;37(8): 895–900.
   PubMedGoogle Scholar
• Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 1997;24(4):654–62.
   PubMedGoogle Scholar
• Weiner ES, Abeles M. Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation. J Rheumatol. 1989; 16(5):604–8.
   PubMedGoogle Scholar
• Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA. 1960;174:966–71.
   PubMed Web of Science ®Google Scholar
• Leventhal GH, Dorfman HD. Aseptic necrosis of bone in systemic lupus erythematosus. Semin Arthritis Rheum. 1974;4(1):73–93.
   PubMedGoogle Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Akbarian M, Faezi ST, Gharibdoost F, Shahram F, Nadji A, Jamshidi AR, et al. Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. Int J Rheum Dis. 2010;13(4):374–9.
   PubMedGoogle Scholar
• Abu-Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol. 2003;25(1):13–24.
   PubMedGoogle Scholar
• Sayarlioglu M, Yuzbasioglu N, Inanc M, Kamali S, Cefle A, Karaman O, et al. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int. 2012;32(1):177–82.
   PubMedGoogle Scholar
• Kerachian MA, Seguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009;114(3–5):121–8.
   PubMedGoogle Scholar
• Prasad R, Ibanez D, Gladman D, Urowitz M. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients. Lupus. 2007;16(3):157–62.
   PubMedGoogle Scholar
• Fialho SC, Bonfa E, Vitule LF, D’Amico E, Caparbo V, Gualandro S, et al. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus. 2007;16(4):239–44.
   PubMedGoogle Scholar
• Hungerford DS. Pathogenetic considerations in ischemic necrosis of bone. Can J Surg. 1981;24(6):583–7, 90.
   PubMedGoogle Scholar
• Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum. 2003;48(3):732–6.
   PubMedGoogle Scholar
• Yang HI, Choi BS, Park SH, Lee SH, Cho CS, Kim HY. The avascular necrosis of bone in SLE. J Korean Rheum Assoc. 1996;3(2):118–25.
   Google Scholar
• Mielants H, Veys EM, DeBussere A, van der Jeught J. Avascular necrosis and its relation to lipid and purine metabolism. J Rheumatol. 1975;2(4):430–6.
   PubMedGoogle Scholar
• Moskal JT, Topping RE, Franklin LL. Hypercholesterolemia: an association with osteonecrosis of the femoral head. Am J Orthop (Belle Mead NJ). 1997;26(9):609–12.
   PubMedGoogle Scholar
• Calvo-Alen J, McGwin G, Toloza S, Fernandez M, Roseman JM, Bastian HM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis. 2006;65(6):785–90.
   PubMedGoogle Scholar
• Jones JP Jr. Fat embolism and osteonecrosis. Orthop Clin North Am. 1985;16(4):595–633.
   PubMedGoogle Scholar
• Cavallasca JA, Laborde HA, Araujo MB, Nasswetter GG. Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome. Clin Rheumatol. 2005;24(4): 406–8.
   PubMedGoogle Scholar
• Belmont HM, Lydon E. Avascular necrosis prevention with lipitor in lupus erythematosus. Lupus. 2005;14:869–70.
   PubMedGoogle Scholar